The Operating Theatre Journal - Journal - Page 18
DePuy Synthes Receives UKCA Mark accreditation for the VELYS™ RoboticAssisted Solution Designed for use with the ATTUNE™ Total Knee System
The VELYS™ Robotic-Assisted Solution features a clear user interface, streamlined clinical application, adaptable workflow,
and fast registration process which aims to improve procedural efficiency in total knee arthroplasty.1
DePuy Ireland UC, County Cork, Ireland –
April 28, 2023 – Today, Johnson & Johnson
MedTech* announced that the VELYS™ RoboticAssisted Solution from DePuy Synthes**, the
Orthopaedics Company of Johnson & Johnson,
has received UKCA Mark accreditation from
the British Standards Institution (BSI) for use
in total knee arthroplasty. The UKCA Mark
accreditation is the latest milestone towards
global expansion of the VELYS™ RoboticAssisted Solution, which to date has launched
in seven key markets and opens the door to
EMEA-wide launches over the coming months.
With a growing and aging patient population,
demand for robotically assisted total joint
replacement surgery is increasing.2 Across
the industry, data shows up to 20% of knee
replacement patients aren’t satisfied with
the outcome of their surgery.3,4 Enhanced
alignment and positioning observed with
robotic total knee arthroplasty may help
contribute to improved patient-reported
outcome measures (PROMs) and reduced
pain.5,6
Mr Benjamin Bloch, a consultant orthopaedic
surgeon with a special interest in hip and knee
surgery at Nottingham University Hospitals
NHS Trust, believes robotics technology will
give him more confidence in the accuracy
of the planning and execution of his knee
replacement surgeries.
“In the past, new technology has been
introduced with a peak of interest and then
sometimes this falls away with time. With
robotics I really do believe this excitement
will be sustained in the orthopaedic
community. There will be a learning curve,
but this technology could potentially improve
efficiencies and outcomes for patients. Better
outcomes means fewer patients returning in
follow-up clinics or for revision surgery, which
gives you more time to treat the thousands of
new patients on the waiting list.”
“For me, particularly with knee replacements,
robotics provides an opportunity to get a more
accurate intraoperative assessment of soft
tissue balancing, and the ability to make tiny
adjustments such as 1 degree of flexion on the
femur or 0.5 degrees of adjustment to tibial
alignment to get the knee perfectly balanced.
You can plan and see it in real-time before you
do your cuts which I find really quite exciting.
I suspect in 15-20 years time, our idea of what
a knee replacement should look like could
change quite dramatically.”
The VELYS Robotic-Assisted Solution is a
first-of-its-kind table mounted solution,
with a streamlined, efficient design that
integrates into surgeons’ current workflow.1,7
The system gives surgeons the control they
are used to and allows them to retain their
preferred technique without the increased
risk of damage to the soft tissue envelope.7,8
It utilises NATURAL CONTROL™ Technology,
a proprietary technology that maintains
the saw cut plane to help execute precise,
reproducible surgeon- controlled cuts without
the need for a cutting block. 7
18
The VELYS™ Robotic-Assisted Solution works
exclusively with the ATTUNE™ Knee System,
which has been shown to improve patientreported outcomes by working in harmony
with the patient’s anatomy to deliver both
stability and motion.9-12 Together, these
technologies aim to define a high standard for
patient performance and elevate the overall
knee replacement experience.
“We have a significant opportunity in the
UK to help our healthcare providers improve
clinical outcomes and increase satisfaction for
knee patients, especially as they tackle some
of the biggest challenges they’ve ever had to
face.” says Hugo Breda, Managing Director for
Johnson & Johnson MedTech UK & Ireland.
“Together, the ATTUNE™ Total Knee and the
VELYS Robotic Assisted Solution is highly
differentiated combination of robotic and
digital surgery. It’s a more attractive clinical
solution that any other option on the market
right now and the addition of VELYS™ Robotic
Assisted Solution to our VELYS™ Digital
Surgery Platform is another step we’re taking
to continue our global vision to be the most
personalised and connected orthopaedics
company.”
Today is an important milestone in our digital
surgery offering. In the coming months there
will be more exciting announcements as we
start to roll out the VELYS Robotic-Assisted
Solution.
Reference:
1.
DePuy Synthes User Experience Evaluation of the VELYS
Robotic-Assisted Solution for Total Knee. July 2020.
Windchill #103744839
2.
Millennium Research Group, Inc. Orthopaedic Surgical
Robotic Devices. 2018; M360SU0001
3.
Bourne RB, Chesworth B, Davis A, Mahomed N, Charron
K. Comparing patient outcomes after THA and TKA: is
there a difference? Clin Orthop Relat Res. 2010;468:542546.
4. Gunaratne R, Pratt DN, Banda J, Fick DP, Khan RJK,
Robertson BW. Patient dissatisfaction following
total knee arthroplasty: a systematic review of the
literature. J Arthroplasty 2017; 32:3854-3860.
5.
Ren Y, Cao S, Wu J, Weng X, Feng B. Efficacy and
reliability of active robotic-assisted total knee
arthroplasty compared with conventional total knee
arthroplasty: a systematic review and meta-analysis.
Postgrad Med J. 2019;95(1121):125-133
6. Agarwal et al. Clinical and Radiological Outcomes in
Robotic-Assisted Total Knee Arthroplasty; The Journal
of Arthroplasty 35 (2020) 3393e3409
7.
Doan, G.W., et al., Image-Free Robotic-Assisted
Total Knee Arthroplasty Improves Implant Alignment
Accuracy: A Cadaveric Study. J Arthroplasty, 2022.
37(4): p. 795-801.
8. Courtis et al. Assessment Of Soft Tissue Following Use
Of A Novel Concept For Robotic-assisted Total Knee; ORS
2021 Annual Meeting Paper No. 1085.
9.
Hamilton WG, Brenkel I, Clatworthy M, et al.
Comparison of existing and new total knee arthroplasty
implant systems from the same manufacturer: a
prospective, multicenter study, 2019. Poster presented
at: American Academy of Orthopaedic Surgeons 2019
Annual Meeting; March 12–16, 2019; Las Vegas, NV.
Poster PO614.
10. Fisher D, Parkin D. Optimizing the value of your
patients’ TKA: how to leverage data from patient
reported outcomes. Becker’s Hospital Review webinar.
October 3, 2019. Accessed October 18, 2019. www.
ATTUNEevidence.com/clinical-evidence.
For more information on the ATTUNE™ Knee
visit https://www.jnjmedtech.com/en-GB/
product/attune-knee-system
11. Ranawat CS, White PB, West S, Ranawat AS. Clinical and
radiographic results of ATTUNE and PFC SIGMA knee
designs at 2-year follow-up: a prospective matched-pair
analysis. J Arthroplasty. 2017;32:431-436.
* Comprising the surgery, orthopaedics, vision
and interventional solutions businesses within
Johnson & Johnson’s MedTech segment.
12. Indelli PF, Pipino G, Johnson P, Graceffa A, Marcucci M.
Posterior-stabilized total knee arthroplasty: a matched
pair analysis of a classic and its evolutional design.
Arthroplasty Today. 2016;2:193-198.
** DePuy Synthes represents the products and
services of DePuy Synthes Sales, Inc., and its
affiliates.
*** Hugo Breda is an employee of Medical Device
Business Services, Inc.
THE OPERATING THEATRE JOURNAL
www.otjonline.com